文献速递淋巴瘤浆细胞疾病

新诊断淋巴瘤与骨髓瘤患者的焦虑和抑郁

Anxiety and depression among patients newly diagnosed with lymphoma and myeloma.
PubMed 文献 · Blood Adv · 2025-01-01

2021年7月至2022年9月对确诊6个月内的成人淋巴瘤或骨髓瘤患者进行调查,200例纳入分析(应答率74.9%)。56.2%存在临床显著焦虑和/或抑郁症状,焦虑52.0%、抑郁27.5%,抑郁与较低生活质量相关。

要点

  • 新诊断淋巴瘤或骨髓瘤患者中56.2%存在临床显著焦虑和/或抑郁症状。
  • 焦虑52.0%(95%CI 44.9-59.1),抑郁27.5%(95%CI 21.6-34.3)。
  • 抑郁与较低生活质量相关(校正均值差-22.0,95%CI -28.1至-15.9)。

核心结论

  • 超过半数新诊断淋巴瘤或骨髓瘤患者经历临床显著的焦虑或抑郁症状,并伴生活质量受损。
  • 这些发现强调对该人群进行系统心理健康筛查和心理干预的必要性。

研究设计与样本

  • 2021年7月至2022年9月开展的调查研究,纳入确诊淋巴瘤或骨髓瘤6个月内的成人患者。
  • 共200例患者纳入分析,应答率74.9%;45.5%为女性,55.5%年龄≥60岁。
  • 临床显著焦虑和抑郁症状定义为医院焦虑抑郁量表相应分量表评分≥8分。
  • 采用多变量分析评估与焦虑/抑郁症状相关的社会人口学因素及症状与生活质量的关系。

主要发现

  • 56.2%的患者存在临床显著焦虑和/或抑郁症状。
  • 焦虑52.0%(95%CI 44.9-59.1),抑郁27.5%(95%CI 21.6-34.3)。
  • 较低财务满意度(AOR 2.43;95%CI 1.25-4.78)和较高医疗不信任水平(AOR 2.09;95%CI 1.10-4.02)与焦虑 odds 升高相关。
  • 较低财务满意度(AOR 2.12;95%CI 1.07-4.30)和较低社会支持水平(AOR 2.88;95%CI 1.42-6.00)与抑郁 odds 升高相关。
  • 抑郁与较低生活质量相关(校正均值差-22.0;95%CI -28.1至-15.9)。

关键数值与推荐

  • 临床显著焦虑和抑郁症状定义为医院焦虑抑郁量表相应分量表评分≥8分。
  • 较低财务满意度(AOR 2.43;95%CI 1.25-4.78)与焦虑 odds 升高相关。
  • 较高医疗不信任水平(AOR 2.09;95%CI 1.10-4.02)与焦虑 odds 升高相关。
  • 较低财务满意度(AOR 2.12;95%CI 1.07-4.30)与抑郁 odds 升高相关。
  • 较低社会支持水平(AOR 2.88;95%CI 1.42-6.00)与抑郁 odds 升高相关。

临床怎么用

  • 作者认为这些发现强调需要对淋巴瘤或骨髓瘤患者进行系统心理健康筛查和心理干预。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although lymphoma and myeloma confer physical and psychological burden, data are limited regarding anxiety and depression symptoms in affected patients. We conducted a survey between July 2021 and September 2022 to characterize anxiety and depression in a cohort of adult patients, within 6 months of a lymphoma or myeloma diagnosis. Clinically significant anxiety and depression symptoms were defined as scores of ≥8 on the corresponding subscales of the Hospital Anxiety and Depression Scale. We assessed sociodemographic factors associated with anxiety/depression symptoms and examined the relationship between anxiety/depression symptoms and quality of life (QOL) in multivariable analyses. Our cohort included 200 patients (response rate, 74.9%), of whom 45.5% were female, and 55.5% were aged ≥60 years. Over half of the cohort (56.2%) had clinically significant anxiety and/or depression symptoms, with 52.0% (95% confidence interval [CI], 44.9-59.1) meeting the cutoff for anxiety and 27.5% (95% CI, 21.6-34.3) for depression. Lower financial satisfaction (adjusted odds ratio [AOR], 2.43; 95% CI, 1.25-4.78) and greater levels of medical mistrust (AOR, 2.09; 95% CI, 1.10-4.02) were associated with higher odds of anxiety. Lower financial satisfaction (AOR, 2.12; 95% CI, 1.07-4.30) and lower levels of social support (AOR, 2.88; 95% CI, 1.42-6.00) were associated with higher odds of depression. Depression was associated with lower QOL (adjusted mean difference, -22.0; 95% CI, -28.1 to -15.9). More than half of patients newly diagnosed with lymphoma or myeloma experience clinically significant anxiety or depression symptoms, with associated detriment to their QOL. These findings underscore the need for systematic mental health screening and psychological interventions for this population.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Odejide OO, Cronin AM, Gray TF, et al. Anxiety and depression among patients newly diagnosed with lymphoma and myeloma. Blood Adv. 2025. PMID: 39841959. doi:10.1182/bloodadvances.2024014821

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。